Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Muller

Showing results (1191-1200 of 1,237) with videos related to

Pageof 124
Sort By:
Acta Neuropsychiatrica|March 12, 2016
Dynamic magnetic resonance imaging and spectroscopie of experimental brain injuryK Nicolay, R M Dijkhuizen, A van der Toorn, et al.
The Journal of Clinical Investigation|February 16, 2023
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionIpshita Nandi, Harvey W Smith, Virginie Sanguin-Gendreau, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Nature Communications|October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrenceYu Gu, Tarek Taifour, Tung Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
The Journal of Investigative Dermatology|February 8, 2013
Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cellsAngelic M G van der Aar, Daisy I Picavet, Femke J Muller, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Immune response to SARS-CoV-2 in the nasal mucosa in children and adultsClarissa M Koch, Andrew D Prigge, Kishore R Anekalla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2022
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancerJennifer F Knight, Robert Lesurf, Hong Zhao, et al.
Oncogene|May 15, 2012
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasionP A J Muller, A G Trinidad, P Timpson, et al.
Pageof 124

Showing results (1191-1200 of 1,237) with videos related to

Sort By:
Pageof 124
Acta Neuropsychiatrica|March 12, 2016
Dynamic magnetic resonance imaging and spectroscopie of experimental brain injuryK Nicolay, R M Dijkhuizen, A van der Toorn, et al.
The Journal of Clinical Investigation|February 16, 2023
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionIpshita Nandi, Harvey W Smith, Virginie Sanguin-Gendreau, et al.
Cancer Research|September 5, 2006
p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signalingJames Hulit, Richard J Lee, Zhiping Li, et al.
Nature Communications|October 25, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrenceYu Gu, Tarek Taifour, Tung Bui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2018
Host <i>IDO2</i> Gene Status Influences Tumor Progression and Radiotherapy Response in <i>KRAS</i>-Driven Sporadic Pancreatic CancersAvinoam Nevler, Alexander J Muller, Erika Sutanto-Ward, et al.
The Journal of Investigative Dermatology|February 8, 2013
Langerhans cells favor skin flora tolerance through limited presentation of bacterial antigens and induction of regulatory T cellsAngelic M G van der Aar, Daisy I Picavet, Femke J Muller, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
Immune response to SARS-CoV-2 in the nasal mucosa in children and adultsClarissa M Koch, Andrew D Prigge, Kishore R Anekalla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2022
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancerJennifer F Knight, Robert Lesurf, Hong Zhao, et al.
Oncogene|May 15, 2012
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasionP A J Muller, A G Trinidad, P Timpson, et al.
Pageof 124